Oncolytics Biotech Inc.
(ONCY)
undefined
undefined%
At close: undefined
0.82
0.79%
After-hours Dec 13, 2024, 06:31 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
Net Income | -27.75M | -24.84M | -26.30M | -22.51M | -33.12M | -17.04M | -15.62M | -15.14M | -13.72M | -18.62M | -23.53M | -36.37M | -29.04M | -19.97M | -17.00M | -17.55M | -15.64M | -14.30M | -12.78M | -12.96M | -8.54M | -6.09M | -6.17M | -3.61M | -574.46K |
Depreciation & Amortization | 403.00K | 392.00K | 452.06K | 446.19K | 485.57K | 95.38K | 90.77K | 162.23K | 180.41K | 163.50K | 131.62K | 109.28K | 92.59K | 63.16K | 257.25K | 410.25K | 1.00M | 926.68K | 855.99K | 751.75K | 663.52K | 574.24K | 465.45K | 205.20K | 1.68K |
Stock-Based Compensation | 2.07M | 2.38M | 3.83M | 2.56M | 1.47M | 1.42M | 578.70K | 406.08K | 429.54K | 980.33K | 424.38K | 730.75K | 1.81M | 3.25M | 444.26K | 64.04K | - | - | - | - | - | - | - | - | - |
Other Working Capital | 1.26M | 46.00K | -131.59K | -1.77M | 221.34K | -862.76K | 4.95M | 1.95M | -957.16K | -2.36M | -1.31M | 1.18M | 3.56M | -1.50M | -663.81K | 1.79M | 530.30K | 789.15K | 584.76K | -69.06K | -486.17K | -1.12M | 1.77M | 376.77K | 38.43K |
Other Non-Cash Items | -4.93M | -1.68M | 91.73K | 68.53K | 94.82K | 75.78K | -124.79K | 406.08K | 429.54K | 980.33K | 424.38K | 730.75K | 814.91K | -19.63M | 116.02K | 64.04K | 539.16K | 426.32K | 288.61K | 3.05M | 2.89M | -1 | - | - | - |
Deferred Income Tax | - | - | 408.56K | -2.85M | 12.96M | -374.34K | - | -545.89K | -1.25M | -737.78K | -514.11K | -640.86K | - | 19.97M | - | -64.04K | - | - | - | - | - | -647.62K | -340.57K | -126.81K | - |
Change in Working Capital | 1.76M | 391.00K | -907.99K | 209.78K | -1.80M | 3.90M | 180.85K | 2.23M | -1.11M | -2.44M | -1.37M | 1.19M | 3.79M | -1.72M | -642.27K | 1.79M | 530.30K | 789.15K | 584.76K | -69.06K | -486.17K | -1.12M | 1.77M | 376.77K | 38.43K |
Operating Cash Flow | -28.45M | -23.36M | -22.43M | -22.07M | -19.91M | -11.92M | -14.89M | -12.48M | -15.03M | -19.68M | -24.44M | -34.26M | -22.54M | -18.03M | -16.82M | -15.29M | -13.57M | -12.16M | -11.05M | -9.22M | -5.48M | -7.26M | -4.27M | -3.16M | -534.35K |
Capital Expenditures | -8.00K | -55.00K | -285.95K | -29.30K | -10.90K | -107.47K | -105.77K | -23.53K | -108.27K | -152.75K | -254.83K | -126.41K | -257.79K | -133.53K | -9.76K | -111.58K | -944.72K | -35.84K | -61.31K | -974.04K | -1.10M | -1.05M | -585.51K | -48.56K | -19.97K |
Acquisitions | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -4.68B | - | - | - | - | - | - | - | - | - |
Purchase of Investments | - | -20.35M | - | - | - | - | - | -27.82K | -29.29K | - | - | -32.44K | - | -1.93M | -1.76M | -347.90K | -949.50K | -1.04M | -22.20M | -6.78M | -18.11M | - | - | - | - |
Sales Maturities Of Investments | 20.23M | - | - | - | - | - | 2.09M | - | - | - | - | - | 1.67M | - | 6.12M | 13.00M | 6.57M | 13.81M | 6.66M | 3.11M | - | - | - | - | - |
Other Investing Acitivies | - | -20.35K | - | - | - | - | 2.09M | -27.82 | -29.29 | -30.04K | -32.42K | -32.44 | - | - | -0.00 | 4.68B | - | -842.61K | -1.03M | 133.61K | 3.00M | -147.47K | - | -324.26K | -50.29K |
Investing Cash Flow | 20.22M | -20.40M | -285.95K | -29.30K | -10.90K | -107.47K | 1.98M | -51.35K | -137.56K | -182.79K | -287.25K | -158.85K | 1.41M | -2.06M | 4.35M | 12.54M | 4.68M | 11.89M | -16.62M | -4.50M | -16.21M | -1.20M | -585.51K | -372.82K | -70.26K |
Debt Repayment | -407.00K | -381.00K | -366.00K | -461.00K | -447.50K | - | - | - | 19.36M | 1.21M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 150.00K |
Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Financial Acitivies | 781.00K | 12.00K | 469.68K | 1.94M | 3.47M | 124.95K | 343.44K | - | -19.36M | -1.21M | 179.24K | 1.08M | 14.82M | 528.21K | 17.01M | 41.60K | - | - | 15.40M | 6.22M | 15.30M | 1.77M | - | 3.00M | 1.90M |
Financial Cash Flow | 31.99M | 12.21M | 33.02M | 39.77M | 21.02M | 13.30M | 12.81M | 956.13K | 23.67M | 9.04M | 30.40M | 20.85M | 14.82M | 27.29M | 38.80M | 3.46M | 12.11M | 241.40K | 18.78M | 23.50M | 16.00M | 1.80M | 2.21M | 16.60M | 5.15M |
Net Cash Flow | 23.25M | -29.60M | 10.04M | 17.07M | 448.14K | 1.86M | -198.16K | -11.98M | 9.86M | -11.07M | 5.90M | -13.60M | -6.38M | 6.85M | 26.20M | 714.80K | 3.22M | -19.85K | -8.90M | 9.77M | -5.68M | -6.65M | -2.65M | 13.07M | 4.55M |
Free Cash Flow | -28.46M | -23.41M | -22.72M | -22.10M | -19.92M | -12.03M | -15.00M | -12.50M | -15.14M | -19.83M | -24.70M | -34.38M | -22.80M | -18.17M | -16.83M | -15.40M | -14.51M | -12.19M | -11.11M | -10.20M | -6.57M | -8.31M | -4.86M | -3.21M | -554.32K |